Liposome for Vaccine Development
Liposomes and liposome-derived nanovesicles have become important carrier systems in vaccine development and the interest for liposome-based vaccines has markedly increased. The key advantages of liposomes as a vaccine delivery system are their ability to protect antigens against degradation, carry single or multiple hydrophilic and lipophilic antigens, control the release of antigens, enhance cellular uptake, and improve antigen-specific immune responses. Creative Biolabs is determined to satisfy the growing need for formulation development of pharmaceutical/biotech industries. We aim to provide the choice in drug delivery, particularly in formulating challenging compounds with liposomes and other novel nano-enabled delivery technologies. Our liposomes with competitive quality and price advantage will be your best choice.
| CAT | Product Name | Product Overview | Type | Datasheet | Size | Price |
|---|---|---|---|---|---|---|
| VCar-Ly127 | PS PEG-NHS (5 kDa) | PS, Phosphatidylserine, 3-sn-Phosphatidyl-L-serine, PS PEG-NHS is a phospholipid PEG conjugate with NHS modified. | Liposome |  |
25 mg |
$1280.00 |
| VCar-Ly128 | Stearic acid PEG (5 kDa) | Stearic acid, an 18 carbon saturated fatty acid lipid with excellent hydrophobicity, stearic acid PEG is a phospholipid PEG conjugate. | Liposome | |
100 mg |
$1180.00 |
| VCar-Ly129 | Stearic acid PEG (2 kDa) | Stearic acid, an 18 carbon saturated fatty acid lipid with excellent hydrophobicity, stearic acid PEG is a phospholipid PEG conjugate. | Liposome | |
100 mg |
$1180.00 |
| VCar-Ly130 | Stearic acid PEG-Mal (3 kDa) | Stearic acid, an 18 carbon saturated fatty acid lipid with excellent hydrophobicity, stearic acid PEG-Mal is a phospholipid PEG conjugate with maleimide modified. | Liposome | |
100 mg |
$1180.00 |
| VCar-Ly131 | Stearic acid PEG-Mal (2 kDa) | Stearic acid, an 18 carbon saturated fatty acid lipid with excellent hydrophobicity, stearic acid PEG-Mal is a phospholipid PEG conjugate with maleimide modified. | Liposome | |
100 mg |
$1180.00 |
| VCar-Ly132 | Stearic acid PEG-NHS (3 kDa) | Stearic acid, an 18 carbon saturated fatty acid lipid with excellent hydrophobicity, stearic acid PEG-NHS is a phospholipid PEG conjugate with NHS modified. | Liposome | |
100 mg |
$1180.00 |
| VCar-Ly133 | Stearic acid PEG-NHS (2 kDa) | Stearic acid, an 18 carbon saturated fatty acid lipid with excellent hydrophobicity, stearic acid PEG-NHS is a phospholipid PEG conjugate with NHS modified. | Liposome | |
100 mg |
$1180.00 |
| VCar-Ly134 | Stearic acid PEG-Amine (3 kDa) | Stearic acid, an 18 carbon saturated fatty acid lipid with excellent hydrophobicity, stearic acid PEG-Amine is a phospholipid PEG conjugate with amine modified. | Liposome | |
100 mg |
$1180.00 |
| VCar-Ly135 | Stearic acid PEG-SH (3 kDa) | Stearic acid, an 18 carbon saturated fatty acid lipid with excellent hydrophobicity, stearic acid PEG-SH is a phospholipid PEG conjugate with thiol modified. | Liposome | |
50 mg |
$1180.00 |
| VCar-Ly136 | Stearic acid PEG-COOH (3 kDa) | Stearic acid, an 18 carbon saturated fatty acid lipid with excellent hydrophobicity, stearic acid PEG-COOH is a phospholipid PEG conjugate with acid modified. | Liposome | |
50 mg |
$1180.00 |
| VCar-Ly137 | Stearic acid PEG-Fluorescein (3 kDa) | Stearic acid, an 18 carbon saturated fatty acid lipid with excellent hydrophobicity, stearic acid PEG-Fluorescein is a phospholipid PEG conjugate with fluorescein modified. | Liposome | |
25 mg |
$1180.00 |
| VCar-Ly138 | Palmitic acid PEG (5 kDa) | Palmitic acid, a 16 carbon saturated fatty acid lipid with excellent hydrophobicity, palmitic acid PEG is a phospholipid PEG conjugate. | Liposome | |
100 mg |
$1180.00 |
| VCar-Ly139 | Palmitic acid PEG (2 kDa) | Palmitic acid, a 16 carbon saturated fatty acid lipid with excellent hydrophobicity, palmitic acid PEG is a phospholipid PEG conjugate. | Liposome | |
100 mg |
$1180.00 |
| VCar-Ly140 | Palmitic acid PEG-Mal (3 kDa) | Palmitic acid, a 16 carbon saturated fatty acid lipid with excellent hydrophobicity, palmitic acid PEG-Mal is a phospholipid PEG conjugate with maleimide modified. | Liposome | |
100 mg |
$1180.00 |
| VCar-Ly141 | Palmitic acid PEG-Mal (2 kDa) | Palmitic acid, a 16 carbon saturated fatty acid lipid with excellent hydrophobicity, palmitic acid PEG-Mal is a phospholipid PEG conjugate with maleimide modified. | Liposome | |
100 mg |
$1180.00 |
| VCar-Ly142 | Palmitic acid PEG-NHS (3 kDa) | Palmitic acid, a 16 carbon saturated fatty acid lipid with excellent hydrophobicity, palmitic acid PEG-NHS is a phospholipid PEG conjugate with NHS modified. | Liposome | |
100 mg |
$1180.00 |
| VCar-Ly143 | Palmitic acid PEG-NHS (2 kDa) | Palmitic acid, a 16 carbon saturated fatty acid lipid with excellent hydrophobicity, palmitic acid PEG-NHS is a phospholipid PEG conjugate with NHS modified. | Liposome | |
100 mg |
$1180.00 |
| VCar-Ly144 | Palmitic acid PEG-COOH (3 kDa) | Palmitic acid, a 16 carbon saturated fatty acid lipid with excellent hydrophobicity, palmitic acid PEG-COOH is a phospholipid PEG conjugate with acid modified. | Liposome | |
100 mg |
$1180.00 |
| VCar-Ly145 | Palmitic acid PEG-COOH (2 kDa) | Palmitic acid, a 16 carbon saturated fatty acid lipid with excellent hydrophobicity, palmitic acid PEG-COOH is a phospholipid PEG conjugate with acid modified. | Liposome | |
100 mg |
$1180.00 |
| VCar-Ly146 | Palmitic acid PEG-Amine (3 kDa) | Palmitic acid, a 16 carbon saturated fatty acid lipid with excellent hydrophobicity, palmitic acid PEG-Amine is a phospholipid PEG conjugate with amine modified. | Liposome | |
100 mg |
$1180.00 |
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
